Abstract:The central nervous system (CNS) has been referred to as the "immunological privileged site". However, it is now clear that the privileged status of the CNS is a result of a balance between immune privilege and effective response. In vitro, human bone marrow mesenchymal stem cells (MSCs) have the ability to differentiate into neurons. Based on this biological attribute we gain the possibility by means of using MSCs as the donors to develop a future cell therapy in clinical application. But using MSCs as donor cells inevitably raises the question as to whether these donor cells would be immunogenic, and if so, would they be rejected after transplantation. To investigate this, human MSCs were cultured in vitro and induced to differentiate along neuronal lineage. The expression of human leukocyte antigen (HLA) class I and class II molecules and the co-stimulatory protein CD80 were increased on the surface of MSCs in the course of neuronal differentiation. But neither of the co-stimulatory proteins, CD40 or CD86, was expressed. After IFN-gamma exposure, the expression of the HLA molecules was further enhanced, but the co-stimulatory proteins were unaffected. MSCs that had been differentiated along neuronal lineage were not capable of inducing the proliferation of peripheral blood lymphocytes (PBLs). Even after IFN-gamma exposure, PBLs remained unresponsive. Furthermore, MSCs differentiated along neuronal lineage suppressed the proliferation of PBLs induced by allogeneic PBLs and mitogens. The mechanisms involved in the immunosuppression may be related to the effect of soluble factors and cell-cell interactions of neuronal differentiated MSCs and PBLs. From the above data we suggested that the low immunogenicity and immunomodulatory function of MSCs in the course of neuronal differentiation in vitro, which will be helpful to further investigation in order to establish the new way for future medical application.

Effects of mesenchymal stromal cells on human myeloid dendritic cell differentiation and maturation in a humanized mouse model

Immunomodulative Effects of Mesenchymal Stem Cells Derived from Human Embryonic Stem Cells in Vivo and in Vitro

Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34+ cells.

Effects of Mesenchymal Stem Cells from Human Induced Pluripotent Stem Cells on Differentiation, Maturation, and Function of Dendritic Cells

[The Effect of Murine Mesenchymal Stem Cells on the Differentiation and Function of Allogenetic Bone Marrow-Derived Dendritic Cells.].

Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells

Inhibitory effects of neural stem cells derived from human embryonic stem cells on differentiation and function of monocyte-derived dendritic cells

[The Effect of Co-Transplantation of Bone Marrow-Derived Mesenchymal Stem Cells and Islet on Maturation and Function of Bone Marrow-Derived Dendritic Cells in Recipient Mice].

Mesenchymal Stem Cells Tune the Development of Monocyte-Derived Dendritic Cells Toward a Myeloid-Derived Suppressive Phenotype through Growth-Regulated Oncogene Chemokines

Contrariety of Human Bone Marrow Mesenchymal Stromal Cell Functionality in Modulating Circulatory Myeloid and Plasmacytoid Dendritic Cell Subsets

Effects of human dendritic cells derived from CD34(+) cells on the biologic characteristic of bone marrow-derived mesenchymal stem cells]

Effects of Mesenchymal Stem Cell Line on Differentiation and Maturation of Murine Bone Marrow-derived Dendritic Cells

The Immunobiological Development of Human Bone Marrow Mesenchymal Stem Cells in the Course of Neuronal Differentiation.

Immune Regulatory Effect of Human Bone Marrow Mesenchymal Stem Cells on T Lymphocyte

Mouse Flk-1+Sca-1- mesenchymal stem cells: functional plasticity in vitro and immunoregulation in vivo.

Mesenchymal Stromal Cells Prevent Allostimulation In Vivo and Control Checkpoints of Th1 Priming: Migration of Human DC to Lymph Nodes and NK Cell Activation

Immunomodulatory Effects of Mesenchymal Stem Cells Involved in Favoring Type 2 T Cell Subsets

The Immunologic Properties of Undifferentiated and Osteogenic Differentiated Mouse Mesenchymal Stem Cells and Its Potential Application in Bone Regeneration.

Mesenchymal stromal cells inhibit graft-versus-host disease of mice in a dose-dependent manner

Mesenchymal stem cells from human umbilical cord regulate the expression of major histocompatibility complex in human neural stem cells and their lineages

Murine Bone Marrow Mesenchymal Stem Cells Cause Mature Dendritic Cells to Promote T‐Cell Tolerance